For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| WANG, YAO CHIEN |
WANG, YU HUNG |
CHEN, CHIH-HSIANG |
02-22981755 |
No.14-1 Wuquan 7th Rd.Wugu Dist, New Taipei City 24890, Taiwan |
2022/06/24 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
AMED Biomedical focus on the research and development of UV-Cross-linked Hydrogel, and is a professional R&D and manufacturing company for wound dressing launched in the market under the product brand of “HeraDerm”. The HeraDerm wound care dressing product collection was developed using the unique UV hydrogel, featuring advantages including high absorbent capacity, high biocompatibility and usage convenience, and is suitable for wound care after surgery, as well as wound care applications such as bedsores, diabetic feet and venous ulceration as a result of old age. The HeraDerm collection is currently being purchased and used by 19 medical centers in Taiwan, and will continue to strive for improvement in the future to produce more quality products. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
